Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S30-4. doi: 10.1097/IGC.0000000000000293.

Abstract

Small cell carcinomas of the ovary are uncommon and account for less than 1% of ovarian cancers. They were first recognized in 1979, and a number of reports appeared during the next 2 decades. They are highly aggressive tumors and usually carry a poor prognosis, although this may reflect that most are diagnosed at advanced stage; however, those diagnosed as stage 1A have only 30% to 40% of long-term survivors. More reports followed extending our experience in the diagnosis and management of these rare cancers. The classification is described below and shown in Table 1, but a revision is expected to be published from the World Health Organization in 2014.

Publication types

  • Review

MeSH terms

  • Carcinoma, Small Cell / pathology*
  • Carcinoma, Small Cell / therapy
  • Combined Modality Therapy
  • Consensus
  • Female
  • Humans
  • Medical Oncology*
  • Ovarian Neoplasms / pathology*
  • Ovarian Neoplasms / therapy
  • Practice Guidelines as Topic*
  • Societies, Medical